Gene therapy avenues and COVID-19 vaccines

2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines.

Detalles Bibliográficos
Autor principal: Abu Abed, Omar S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170448/
https://www.ncbi.nlm.nih.gov/pubmed/34079091
http://dx.doi.org/10.1038/s41435-021-00136-6
_version_ 1783702247533707264
author Abu Abed, Omar S.
author_facet Abu Abed, Omar S.
author_sort Abu Abed, Omar S.
collection PubMed
description 2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines.
format Online
Article
Text
id pubmed-8170448
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-81704482021-06-02 Gene therapy avenues and COVID-19 vaccines Abu Abed, Omar S. Genes Immun Correspondence 2020 has witnessed unprecedented situations due to coronavirus pandemic that affected all aspects of life. The whole globe lived months of uncertainty before two companies have announced the incredible results of phase III clinical trials for two different mRNA-based vaccines. Nature Publishing Group UK 2021-06-02 2021 /pmc/articles/PMC8170448/ /pubmed/34079091 http://dx.doi.org/10.1038/s41435-021-00136-6 Text en © The Author(s), under exclusive licence to Springer Nature Limited 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Correspondence
Abu Abed, Omar S.
Gene therapy avenues and COVID-19 vaccines
title Gene therapy avenues and COVID-19 vaccines
title_full Gene therapy avenues and COVID-19 vaccines
title_fullStr Gene therapy avenues and COVID-19 vaccines
title_full_unstemmed Gene therapy avenues and COVID-19 vaccines
title_short Gene therapy avenues and COVID-19 vaccines
title_sort gene therapy avenues and covid-19 vaccines
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8170448/
https://www.ncbi.nlm.nih.gov/pubmed/34079091
http://dx.doi.org/10.1038/s41435-021-00136-6
work_keys_str_mv AT abuabedomars genetherapyavenuesandcovid19vaccines

Ejemplares similares